Revision Bulletins

Revision Bulletins are published in USP–NF Online by the first of each month. Each Revision Bulletin includes a notice that provides the reason for the change and the official date. Monograph names listed before April 1, 2021 contain a combined notice and documentary standard; postings after April 1, 2021 provide separate links for the notice and for the standard content. For more information on the Revision Bulletins and the Accelerated Revision process, see USP's Guideline on the Use of Accelerated Processes for Revisions to USP–NF. Archived Revision Bulletins can be found here.

See the Publication & Comment Schedule section for specific posting and official dates.

New and Updated Revision Bulletins

  • Quinidine Gluconate Extended-Release Tablets Notice and Monograph (posted 07–Oct–2021; official 08–Oct–2021)
    • Previously published as a Pending Notice of Intent to Revise
  • Metformin Hydrochloride Extended-Release Tablets Notice and Monograph (posted 16–Sep–2021; official 17–Sep–2021)
    • Previously published as a Pending Notice of Intent to Revise
  • Quetiapine Extended-Release Tablets Notice and Monograph (posted 27–Aug–2021; official 01–Sep–2021)
  • Tranexamic Acid Tablets Notice and Monograph (posted 27–Aug–2021; official 01–Sep–2021)
  • Azeotropic Isopropyl Alcohol Notice and Monograph (posted 30–Jul–2021; official 01–Feb–2022)
  • Isopropyl Alcohol Notice and Monograph (posted 30–Jul–2021; official 01–Feb–2022)
  • Nifedipine Extended-Release Tablets Notice and Monograph (posted 30–Jul–2021; official 01–Aug–2021)
  • Olmesartan Medoxomil Tablets Notice and Monograph (posted 30–Jul–2021; official 01–Aug–2021)
  • Potassium Chloride Extended-Release Tablets Notice and Monograph (posted 30–Jul–2021; official 01–Aug–2021)
  • Sucrose Notice and Monograph (posted 30–Jul–2021; official 01–Aug–2021)
  • Oxcarbazepine Oral Suspension Notice and Monograph (posted 28–Jul–2021; official 29–Jul–2021)
    • Previously published as Pending- Notice of Intent to Revise
  • Baclofen Injection Notice and Monograph (posted 25–Jun–2021; official 01–Jul–2021)
  • Benztropine Mesylate Notice and Monograph (posted 25–Jun–2021; official 01–Jul–2021)
  • Budesonide Notice and Monograph (posted 25–Jun–2021; official 01–Jul–2021)
  • Potassium Citrate Extended-Release Tablets Notice and Monograph (posted 25–Jun–2021; official 01–Jul–2021)
  • Chlorpromazine Hydrochloride Oral Concentrate Notice and Monograph (posted 14–Jun–2021; official 15–Jun–2021)
    • Previously published as Pending- Notice of Intent to Revise

Revision Bulletins

To view Accelerated Revisions by official date, please click here.